Filing Details

Accession Number:
0001104659-23-046897
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-18 20:07:05
Reporting Period:
2023-04-17
Accepted Time:
2023-04-18 20:07:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1297184 Amphastar Pharmaceuticals Inc. AMPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1263136 J William Peters C/O Amphastar Pharmaceuticals, Inc.
11570 6Th Street
Rancho Cucamonga CA 91730
Cfo, Evp & Treasurer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-17 5,632 $13.35 110,780 No 4 M Direct
Common Stock Disposition 2023-04-17 5,632 $42.35 105,148 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2023-04-17 5,632 $0.00 5,632 $13.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
28,990 2027-03-16 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2022.
  2. Shares subject to the option are fully vested and immediately exercisable.